Echogen is Profiled in this Database

Updated At 27 Jan, 2012

Start Free 7 Day Trial Now
Partial description of this company
Novel metal abstraction peptide (MAP) platform technology that delivers platinum to cancer cells by incorporating it into cancer-targeting proteins, thereby improving treatment while limiting side effects and damage to healthy cells

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Echogen plus 5035 other startups.

Start Free 7 Day Trial Now

Learn More About Echogen

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

More

Our Clients